Figure 1
Figure 1. EWALL-PH-01 treatment strategy. ★, PCR analysis; ASP, asparaginase; IDAC, intermediate-dose cytarabine; Cons., consolidation; Dasa, dasatinib; DEXA, dexamethasone; IDMTX, intermediate-dose methotrexate; IT, intrathecal (triple IT, 15 mg MTX, 40 mg AraC, and 40 mg prednisone); 6MP, 6-mercaptopurine; MTX, methotrexate; mo, month; P, prephase with dexamethasone; QD, once a day; VCR, vincristine.

EWALL-PH-01 treatment strategy. ★, PCR analysis; ASP, asparaginase; IDAC, intermediate-dose cytarabine; Cons., consolidation; Dasa, dasatinib; DEXA, dexamethasone; IDMTX, intermediate-dose methotrexate; IT, intrathecal (triple IT, 15 mg MTX, 40 mg AraC, and 40 mg prednisone); 6MP, 6-mercaptopurine; MTX, methotrexate; mo, month; P, prephase with dexamethasone; QD, once a day; VCR, vincristine.

Close Modal

or Create an Account

Close Modal
Close Modal